References
1. Kessing LV, Bauer M, Nolen WA, Severus E, Goodwin GM, Geddes J. Effectiveness of maintenance therapy of lithium vs other mood stabilizers in monotherapy and in combinations: a systematic review of evidence from observational studies. Bipolar Disord 2018; 20: 419-31.
2. BALANCE- investigators-collaborators, Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, Morriss R, Alder N, Juszczak E. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010; 375: 385-95.
3. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet 2012; 379: 721-8.
4. Ott M, Stegmayr B, Salander Renberg E, Werneke U. Lithium intoxication: Incidence, clinical course and renal function - a population-based retrospective cohort study. J Psychopharmacol 2016; 30: 1008-19.
5. Vodovar D, Beaune S, Langrand J, Vicaut E, Labat L, Megarbane B. Assessment of Extracorporeal Treatments in Poisoning criteria for the decision of extracorporeal toxin removal in lithium poisoning. Br J Clin Pharmacol 2020; 86: 560-68.
6. Vodovar D, El Balkhi S, Curis E, Deye N, Megarbane B. Lithium poisoning in the intensive care unit: predictive factors of severity and indications for extracorporeal toxin removal to improve outcome. Clin Toxicol (Phila) 2016; 54: 615-23.
7. Baird-Gunning J, Lea-Henry T, Hoegberg LCG, Gosselin S, Roberts DM. Lithium Poisoning. J Intensive Care Med 2017; 32: 249-63.
8. Verbov JL, Phillips JD, Fife DG. A case of lithium intoxication. Postgrad Med J 1965; 41: 190-2.
9. Schou M. Long-lasting neurological sequelae after lithium intoxication. Acta Psychiatr Scand 1984; 70: 594-602.
10. Adityanjee. The syndrome of irreversible lithium effectuated neurotoxicity. J Neurol Neurosurg Psychiatry 1987; 50: 1246-7.
11. Adityanjee, Munshi KR, Thampy A. The syndrome of irreversible lithium-effectuated neurotoxicity. Clin Neuropharmacol 2005; 28: 38-49.
12. Donaldson IM, Cuningham J. Persisting neurologic sequelae of lithium carbonate therapy. Arch Neurol 1983; 40: 747-51.
13. Kores B, Lader MH. Irreversible lithium neurotoxicity: an overview. Clin Neuropharmacol 1997; 20: 283-99.
14. Roy M, Stip E, Black DN, Lew V, Langlois R. Neurological sequelae following acute lithium poisoning - Review of the literature. Can J Psychiatry 1999; 44: 671-79.
15. Verdoux H, Bourgeois M. [Irreversible neurologic sequelae caused by lithium]. Encephale 1991; 17: 221-4.
16. Cohen WJ, Cohen NH. Lithium carbonate, haloperidol, and irreversible brain damage. JAMA 1974; 230: 1283-87.
17. Tournier M, Neumann A, Pambrun E, Weill A, Chaffiol JP, Alla F, Begaud B, Maura G, Verdoux H. Conventional mood stabilizers and/or second-generation antipsychotic drugs in bipolar disorders: A population-based comparison of risk of treatment failure. J Affect Disord 2019; 257: 412-20.
18. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
19. Decker BS, Goldfarb DS, Dargan PI, Friesen M, Gosselin S, Hoffman RS, Lavergne V, Nolin TD, Ghannoum M, Workgroup E. Extracorporeal Treatment for Lithium Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup. Clin J Am Soc Nephrol 2015; 10: 875-87.
20. Pheterson AD, Miller L, Fox CF, Estroff TW, Sweeney DR. Multifocal neurological impairment caused by infection-induced rise in blood lithium and amitriptyline. Int J Psychiatry Med 1986; 16: 257-62.
21. Yoshimoto Y. A case of lithium intoxication with downbeat vertical nystagmus. Auris Nasus Larynx 1987; 14: 71-5.
22. Lal V, Sardana V, Thussu A, Sawhney I, Prabhakar S. Cerebellar degeneration following neuroleptic malignant syndrome. Postgrad Med J 1997; 73: 735-36.
23. Epstein Y, Albukrek D, Kalmovitc B, Moran DS, Shapiro Y. Heat intolerance induced by antidepressants. Ann N Y Acad Sci 1997; 813: 553-8.
24. Muthane UB, Prasad BN, Vasanth A, Satishchandra P. Tardive Parkinsonism, orofacial dyskinesia and akathisia following brief exposure to lithium carbonate. J Neurol Sci 2000; 176: 78-9.
25. Ozsoy S, Basturk M, Esel E. Cerebellar syndrome in a patient with pneumonia under lithium treatment: A case report. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 1532-4.
26. Araujo LC, Nery-Fernandes F, Quarantini LC, Miranda-Scippa A. Persistent neurotoxicity secondary to lithium use: case report. Revista Brasileira De Psiquiatria 2006; 28: 163-63.
27. Niethammer M, Ford B. Permanent lithium-induced cerebellar toxicity: three cases and review of literature. Mov Disord 2007; 22: 570-3.
28. Tharoor H, Deora S, Chauhan A, Sharma PSVN. Lithium-neuroleptic combination leading to permanent neurological sequelae? German Journal of Psychiatry 2007; 10: 18-20.
29. de Cerqueira ACR, dos Reis MC, Novis FD, Bezerra JMF, de Magalhães GC, Rozenthal M, Nardi AE. Cerebellar degeneration secondary to acute lithium carbonate intoxication. Arquivos de Neuro-Psiquiatria 2008; 66: 578-80.
30. Keltner NL, Grant JS. Irreversible lithium-induced neuropathy: Two cases. Pers Psychiatr Care 2008; 44: 290-93.
31. Fischera M, Anneken K, Evers S, Kloska S, Husstedt IW. Cerebellar atrophy after long-term treatment with low-dose lithium. Pharmacopsychiatry 2009; 42: 125-26.
32. Porto FHG, Leite MAA, Fontenelle LF, Marrocos RP, Szczerback NF, de Freitas MRG. The Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (SILENT): One-year follow-up of a single case. J Neurol Sci 2009; 277: 172-73.
33. Mazzini L, Oggioni GD, Nasuelli N, Servo S, Testa L, Monaco F. Disabling Parkinsonism following brief exposure to lithium carbonate in amyotrophic lateral sclerosis. J Neurol 2011; 258: 333-4.
34. Banwari G, Chaudhary P, Panchmatia A, Patel N. Persistent cerebellar dysfunction following acute lithium toxicity: A report of two cases. Indian J Pharmacol 2016; 48: 331-3.
35. Hallab B, Agoub M, Battas O. Lithium-neuroleptic combination leading to permanent neurological sequelae (case report). Annales Medico-Psychologiques 2017; 175: 862-64.
36. Hallab B, Hallab S, Battas O, Agoub M. Syndrome of irreversible lithium-effectuated neuro-toxicity or SILENT: A case report. Therapie 2017; 72: 403-07.
37. Rossi FH, Rossi EM, Hoffmann M, Liu W, Cruz RR, Antonovich N, Rezaei A, Gonzalez E, Franco MC, Estevez A, Thomas F. Permanent Cerebellar Degeneration After Acute Hyperthermia with Non-toxic Lithium Levels: a Case Report and Review of Literature. Cerebellum 2017; 16: 973-78.
38. Silva AL, Ourique C, Martins F, Frioes F. Syndrome of Irreversible Lithium-Effectuated NeuroToxicity. Acta Medica Portuguesa 2017; 30: 151-53.
39. Fountoulakis KN, Tegos T, Kimiskidis V. Lithium monotherapy-induced tardive dyskinesia. J Affect Disord 2019; 244: 78-79.
40. Baker PC, Price TR, Allen CD. Brain stem and cerebellar dysfunction with Legionnaires’ disease. J Neurol Neurosurg Psychiatry 1981; 44: 1054-6.
41. Habib M, Khalil R, le Pensec-Bertrand D, Ali-Cherif A, Bongrand MC, Crevat A. [Persistent neurological syndrome after treatment with lithium salts. Toxicity of the lithium-neuroleptic combination?]. Rev Neurol (Paris) 1986; 142: 61-4.
42. Servant D, Gaudet Y, Danel T, Goudemand M, Petit H. [Persistent cerebellar syndrome following treatment with lithium salts]. Presse Med 1987; 16: 312.
43. Pelletier J, Habib M, Pellissier JF, Crevat A, Khalil R. [Neurologic sequelae of the neuroleptics-lithium combination: role of hyperthermia]. Rev Med Interne 1991; 12: 187-91.
44. Merle C, Sotto A, Galland MC, Jourdan E, Jourdan J. Persistent cerebellar syndrome after lithium and neuroleptic therapy. Therapie 1998; 53: 511-13.
45. Biscof F, Melms A. Persistent cerebellar deterioration in a patient with lobar pneumonia. Eur Psychiatry 1999; 14: 175–76.
46. Verdoux H, Bourgeois ML. A case of lithium neurotoxicity with irreversible cerebellar syndrome. J Nerv Ment Dis 1990; 178: 761-2.
47. Gille M, Ghariani S, Pieret F, Delbecq J, Depre A, Saussu F, de Barsy T. [Acute encephalomyopathy and persistent cerebellar syndrome after lithium salt and haloperidol poisoning]. Rev Neurol (Paris) 1997; 153: 268-70.
48. Verdoux H, Pambrun E, Cortaredona S, Coldefy M, Le Neindre C, Tournier M, Verger P. Geographical disparities in prescription practices of lithium and clozapine: a community-based study. Acta Psychiatr Scand 2016; 133: 470-80.
49. Bramness JG, Weitoft GR, Hallas J. Use of lithium in the adult populations of Denmark, Norway and Sweden. J Affect Disord 2009; 118: 224-8.
50. Juul-Jensen P, Schou M. Letter: Permanent brain damage after lithium intoxication. Br Med J 1973; 4: 673.
51. Zingraff J, Jungers P, Drueke T, Man NK, Crosnier J. [Accidental lithium poisoning in a patient with chronic hemodialysis]. Nouv Presse Med 1975; 4: 3181.
52. Izzo KL, Brody R. Rehabilitation in lithium toxicity: case report. Arch Phys Med Rehabil 1985; 66: 779-82.
53. Heim J, Pinel JF, Allannic H, Ferrand P, Sabouraud O, Lorcy Y. [A case of permanent neurological sequelae by lithium intoxication during a thyrotoxicosis (author’s transl)]. Sem Hop 1981; 57: 1349-52.
54. Schneider JA, Mirra SS. Neuropathologic correlates of persistent neurologic deficit in lithium intoxication. Ann Neurol 1994; 36: 928-31.
55. van Gaalen J, Kerstens FG, Maas R, Harmark L, van de Warrenburg BPC. Drug-Induced Cerebellar Ataxia: A Systematic Review. Cns Drugs 2014; 28: 1139-53.
56. Goldman SA. FDA MedWatch report: Lithium and neuroleptics in combination: The spectrum of neurotoxicity. Psychopharmacol Bull 1996; 32: 299-309.
57. Verdoux H, Gonzales B, Takei N, Bourgeois M. A survey of prescribing practice of antipsychotic maintenance treatment for manic-depressive outpatients. J Affect Disord 1996; 38: 81-7.
58. Naramoto A, Koizumi N, Itoh N, Shigematsu H. An autopsy case of cerebellar degeneration following lithium intoxication with neuroleptic malignant syndrome. Acta Pathol Jpn 1993; 43: 55-8.
59. Lecamwasam D, Synek B, Moyles K, Ghose K. Chronic lithium neurotoxicity presenting as parkinsons-disease. Int Clin Psychopharmacol 1994; 9: 127-29.
60. Ferbert A, Czernik A. [Persistent cerebellar syndrome following lithium poisoning]. Nervenarzt 1987; 58: 764-70.
61. Peiffer J. Clinical and neuropathological aspects of long-term damage to the central nervous system after lithium medication. Arch Psychiatr Nervenkr (1970) 1981; 231: 41-60.
62. Tesio L, Porta GL, Messa E. Cerebellar syndrome in lithium poisoning: a case of partial recovery. J Neurol Neurosurg Psychiatry 1987; 50: 235.
63. Schou M. Is there a lithium withdrawal syndrome? An examination of the evidence. Br J Psychiatry 1993; 163: 514-8.
64. Goodwin GM. Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. Br J Psychiatry 1994; 164: 149-52.
65. Siskind D, Honer WG, Clark S, Correll CU, Hasan A, Howes O, Kane JM, Kelly DL, Laitman R, Lee J, MacCabe JH, Myles N, Nielsen J, Schulte PF, Taylor D, Verdoux H, Wheeler A, Freudenreich O. Consensus statement on the use of clozapine during the COVID-19 pandemic. J Psychiatry Neurosci 2020; 45: 222-23.
66. Verdoux H, Quiles C, de Leon J. Clinical determinants of fever in clozapine users and implications for treatment management: A narrative review. Schizophr Res 2019; 211: 1-9.
67. de Leon J, Ruan CJ, Schoretsanitis G, De Las Cuevas C. A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology. Psychother Psychosom 2020: 1-15.
68. de Leon J, Sanz EJ, Noren GN, De Las Cuevas C. Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second-generation antipsychotics. World Psychiatry 2020; 19: 120-21.
69. Vodovar D, Megarbane B. Prognosis and outcome of severe lithium poisoning. J Psychopharmacol 2017; 31: 1274-77.
70. Kessing LV, Gerds TA, Knudsen NN, Jorgensen LF, Kristiansen SM, Voutchkova D, Ernstsen V, Schullehner J, Hansen B, Andersen PK, Ersboll AK. Association of Lithium in Drinking Water With the Incidence of Dementia. JAMA Psychiatry 2017; 74: 1005-10.
71. Velosa J, Delgado A, Finger E, Berk M, Kapczinski F, de Azevedo Cardoso T. Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta-analyses. Acta Psychiatr Scand 2020.